Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years
ObjectivesInterstitial lung diseases (ILDs) and pulmonary sarcoidosis represent a group of disorders characterized by diffuse parenchymal lung damage and chronic inflammation, leading to impaired lung function and gas exchange. These conditions may ultimately result in progressive respiratory failur...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1578480/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849693917830709248 |
|---|---|
| author | Mi Zhou Yazhe Zhou Xin Yang Kaizhuo Zhou Xin Zhu |
| author_facet | Mi Zhou Yazhe Zhou Xin Yang Kaizhuo Zhou Xin Zhu |
| author_sort | Mi Zhou |
| collection | DOAJ |
| description | ObjectivesInterstitial lung diseases (ILDs) and pulmonary sarcoidosis represent a group of disorders characterized by diffuse parenchymal lung damage and chronic inflammation, leading to impaired lung function and gas exchange. These conditions may ultimately result in progressive respiratory failure and increased mortality. This study aimed to assess the global, regional, and national burden of ILDs and pulmonary sarcoidosis.MethodsData from the Global Burden of Disease (GBD) 2021 database were used to analyze the incidence, mortality, and disability-adjusted life years (DALYs) associated with ILDs and pulmonary sarcoidosis from 2000 to 2021. Temporal trends were evaluated using Joinpoint regression analysis, and the relationship between disease burden and the sociodemographic index (SDI) was explored by stratifying the data into five SDI categories. Age-standardized rates were calculated to adjust for differences in population structure, and data visualization was performed using R software.ResultsBetween 2000 and 2021, the global burden of ILDs and pulmonary sarcoidosis increased, as reflected by rising age-standardized incidence rates (ASIR), mortality rates (ASMR), and disability-adjusted life years rates (ASDR). Older adults, particularly those aged 75 years and above, bore the highest burden. High-SDI regions exhibited higher ASIR, likely due to better diagnostic capabilities, while low-SDI regions experienced higher ASMR and ASDR, potentially due to limited access to healthcare. Gender differences were observed, with males generally having higher rates than females.ConclusionsDespite advances in diagnostics and treatment over recent decades, the global burden of ILDs and pulmonary sarcoidosis remains substantial, with marked disparities across age groups, genders, and SDI regions. Understanding these epidemiological patterns is essential for developing effective prevention and management strategies. |
| format | Article |
| id | doaj-art-2c80e2b77d2e43bf9dba526687f2890f |
| institution | DOAJ |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-2c80e2b77d2e43bf9dba526687f2890f2025-08-20T03:20:16ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-06-011310.3389/fpubh.2025.15784801578480Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life yearsMi Zhou0Yazhe Zhou1Xin Yang2Kaizhuo Zhou3Xin Zhu4Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaThe First Clinical College of Chongqing Medical University, Chongqing, ChinaThe First Clinical College of Chongqing Medical University, Chongqing, ChinaThe First Clinical College of Chongqing Medical University, Chongqing, ChinaDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaObjectivesInterstitial lung diseases (ILDs) and pulmonary sarcoidosis represent a group of disorders characterized by diffuse parenchymal lung damage and chronic inflammation, leading to impaired lung function and gas exchange. These conditions may ultimately result in progressive respiratory failure and increased mortality. This study aimed to assess the global, regional, and national burden of ILDs and pulmonary sarcoidosis.MethodsData from the Global Burden of Disease (GBD) 2021 database were used to analyze the incidence, mortality, and disability-adjusted life years (DALYs) associated with ILDs and pulmonary sarcoidosis from 2000 to 2021. Temporal trends were evaluated using Joinpoint regression analysis, and the relationship between disease burden and the sociodemographic index (SDI) was explored by stratifying the data into five SDI categories. Age-standardized rates were calculated to adjust for differences in population structure, and data visualization was performed using R software.ResultsBetween 2000 and 2021, the global burden of ILDs and pulmonary sarcoidosis increased, as reflected by rising age-standardized incidence rates (ASIR), mortality rates (ASMR), and disability-adjusted life years rates (ASDR). Older adults, particularly those aged 75 years and above, bore the highest burden. High-SDI regions exhibited higher ASIR, likely due to better diagnostic capabilities, while low-SDI regions experienced higher ASMR and ASDR, potentially due to limited access to healthcare. Gender differences were observed, with males generally having higher rates than females.ConclusionsDespite advances in diagnostics and treatment over recent decades, the global burden of ILDs and pulmonary sarcoidosis remains substantial, with marked disparities across age groups, genders, and SDI regions. Understanding these epidemiological patterns is essential for developing effective prevention and management strategies.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1578480/fullinterstitial lung diseasepulmonary sarcoidosisincidencemortalitydisability-adjusted life yearsaging |
| spellingShingle | Mi Zhou Yazhe Zhou Xin Yang Kaizhuo Zhou Xin Zhu Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years Frontiers in Public Health interstitial lung disease pulmonary sarcoidosis incidence mortality disability-adjusted life years aging |
| title | Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years |
| title_full | Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years |
| title_fullStr | Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years |
| title_full_unstemmed | Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years |
| title_short | Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years |
| title_sort | global regional and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021 a systematic analysis of incidence mortality and disability adjusted life years |
| topic | interstitial lung disease pulmonary sarcoidosis incidence mortality disability-adjusted life years aging |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1578480/full |
| work_keys_str_mv | AT mizhou globalregionalandnationalburdenofinterstitiallungdiseasesandpulmonarysarcoidosisfrom2000to2021asystematicanalysisofincidencemortalityanddisabilityadjustedlifeyears AT yazhezhou globalregionalandnationalburdenofinterstitiallungdiseasesandpulmonarysarcoidosisfrom2000to2021asystematicanalysisofincidencemortalityanddisabilityadjustedlifeyears AT xinyang globalregionalandnationalburdenofinterstitiallungdiseasesandpulmonarysarcoidosisfrom2000to2021asystematicanalysisofincidencemortalityanddisabilityadjustedlifeyears AT kaizhuozhou globalregionalandnationalburdenofinterstitiallungdiseasesandpulmonarysarcoidosisfrom2000to2021asystematicanalysisofincidencemortalityanddisabilityadjustedlifeyears AT xinzhu globalregionalandnationalburdenofinterstitiallungdiseasesandpulmonarysarcoidosisfrom2000to2021asystematicanalysisofincidencemortalityanddisabilityadjustedlifeyears |